Search

everythinglearnresearchcommunity

for

Search:↓

Most pediatric inpatients needed dermatology consultations for unspecified rashes and drug reactions, with varied treatments.

Sunscreen particles were not found in inflamed or fibrotic areas of skin in FFA patients, suggesting no direct link to the disease.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Skin biopsies are recommended for confirming alopecia diagnosis due to variability in clinical assessments; the link between vitamin D levels and alopecia is unclear.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Both parties agree that cell death is important in the hair cycle, but they have different views on the role of the catagen phase and hair shedding.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Male pattern baldness may predict prostate cancer risk.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

There's no strong link between Alopecia Areata, a hair loss condition, and fatty liver, but more research is needed.

Docetaxel treatment for breast cancer can cause permanent hair loss.

Finasteride caused blisters on hands and feet.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

BMP signaling controls hair growth and skin color.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

Hair transplants for male baldness can show inflammation and fibrosis, but more research is needed to confirm LPP presence.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.